MADRID -- The high-dose inactivated influenza vaccine may reduce older people's risk of hospitalization for flu or pneumonia more than a standard-dose shot, according to two large open-label, ...
The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback